Stay Ahead in Fast-Growing Economies.
Browse Reports Now
Buprenorphine Market – In-Deep Analysis Focusing on Market Share 2024-2032
The Buprenorphine Market defines the market of the medicine buprenorphine for the treatment of opioid dependence and pain in the world. Buprenorphine is a partial agonist in the opioid class and is applied to minimize withdrawal and desire in opiate addiction. It is also used for management of pain inclusive of chronic pain disorders. It involves sublingual tablets, extended release injectables, buccal films available in hospitals, pharmacies, and through online sales across the world.
IMR Group
Description
Buprenorphine Market Synopsis:
Buprenorphine Market Size Was Valued at USD 5.44 Billion in 2023, and is Projected to Reach USD 18.25 Billion by 2032, Growing at a CAGR of 14.40% From 2024-2032.
The Buprenorphine Market defines the market of the medicine buprenorphine for the treatment of opioid dependence and pain in the world. Buprenorphine is a partial agonist in the opioid class and is applied to minimize withdrawal and desire in opiate addiction. It is also used for management of pain inclusive of chronic pain disorders. It involves sublingual tablets, extended release injectables, buccal films available in hospitals, pharmacies, and through online sales across the world.
The main growth stimulants in the Buprenorphine Market are high incidence of opioid dependence and increasing demand for medication in patients with opioid addiction. Hence with opioid addiction devastating many communities, governments and health care systems globally have been directing their efforts toward the delivery of improved and more accessible form of treatment. Buprenorphine is used preferably since it relieves opioid cravings, and at the same time has low risk of misuse.
The other important factor is the increasing need for options other than opioid based treatments. As more and more people experience chronic pain, buprenorphine is becoming more widely used because it can help end patient’s pain for a long period and does not pose as many risks as classic opioids. This trend of opting for non-oral analgesics is forunknowable to persist in fuelling the consumption of buprenorphine especially in those areas where prescription opioid abuse is rampant.
Buprenorphine Market Trend Analysis:
Development of advanced formulations
One of the key developments under consideration in the Buprenorphine Market is expanding the range of compounds, including extended-release injectable and buccal films with an attempt to enhance patient compliance. These innovations give more opportunities for patient-consuming persons and make the actions in the sphere of treatment of opioid dependence more comfortable for patients since using them, it is possible to achieve longer activation and less frequent application of the allocated doses. This trend is expected to continue because pharmaceutical firms are already seeking ways on how better to deliver buprenorphine.
Another trend is the growth of interest concerning legal regulation of using buprenorphine in different countries. Bureaucracies are increasingly supporting moderation approaches, such as prescribing of drugs such as buprenorphine to tackle the menace of opioid. Lifting of regulations that hindered the administration of buprenorphine and enhancement of the number of treatment facilities is projected to drive market growth in the next couple of years.
Opioid dependence and pain management challenges are on the rise
The increased growth is the emerging markets where opioid dependence and pain management issues are only growing. Asian Pacific and Latin American countries figure among the emerging importance owing to rising incidence of both opioid dependence and chronic pain. By extending awareness of effectiveness of these products and availability of treatment, the related pharmaceutical companies will be able to widen their markets in those areas.
The constantly increasing trend in the consumption of telemedicine and digital products can become another advantage of buprenorphine distribution. Since telehealth technologies continue to be utilized in managing chronic diseases and substance use disorders, extending buprenorphine-prescribing through telehealth creation could enhance patient convenience and access for treatment in rural areas.
Buprenorphine Market Segment Analysis:
Buprenorphine Market is Segmented on the basis of Product type, application, end user, and region
By Product Type, Sublingual Tablets segment is expected to dominate the market during the forecast period
The Buprenorphine Market can be segmented by product type into three primary forms: For this delivery route, sublingual tablets, extended-release injectable products, and buccal films apply. Sublingual tablets are the most popular product form because of convenience and efficacy in managing opioid dependence.
Long-acting agents, where active substances provide a sustained therapeutic effect, are gradually emerging as popular formulations for patients who should be administered long-term opioid dependence therapy. One of the delivery systemic routes is the buccal films which are effective when placed inside the cheek; it has better bioavailability and reduced side effects from the tablets.
By Application, Pain Management segment expected to held the largest share
The Pain Management segment is anticipated to hold the largest share of the global buprenorphine market over the forecast period. This dominance is attributed to the increasing prevalence of chronic pain conditions such as arthritis, back pain, and cancer-related pain, coupled with the growing demand for effective, long-term opioid therapies. Buprenorphine’s unique pharmacological profile, offering potent analgesia with a lower risk of respiratory depression compared to full agonist opioids, continues to position it as a preferred choice among healthcare providers.
Furthermore, supportive regulatory initiatives aimed at expanding access to pain management solutions and the development of novel buprenorphine delivery systems, such as transdermal patches and extended-release injections, are expected to bolster market growth. Companies investing in innovative formulations stand to capitalize on the expanding patient pool worldwide
Buprenorphine Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
The Buprenorphine market is poised for significant growth, with North America anticipated to dominate during the forecast period. The region’s leadership is driven by a combination of factors, including a well-established healthcare infrastructure, rising incidences of opioid use disorder (OUD), and increasing awareness regarding medication-assisted treatments (MAT). Additionally, strong governmental initiatives and the presence of leading pharmaceutical companies are expected to further support market expansion across the United States and Canada
Favourable regulatory policies and funding programs aimed at combating the opioid crisis are creating an environment conducive to buprenorphine adoption. Strategic collaborations among key industry players and research institutions are accelerating the development and availability of innovative formulations, positioning North America at the forefront of the global buprenorphine market throughout the forecast horizon.
Active Key Players in the Buprenorphine Market
Amgen Inc. (USA)
Bristol-Myers Squibb (USA)
Cadila Healthcare (India)
Gilead Sciences (USA)
Indivior (United Kingdom)
Johnson & Johnson (USA)
Mylan N.V. (USA)
Purdue Pharma L.P. (USA)
Sandoz (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Other Active Players
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Buprenorphine Market by Product Type
4.1 Buprenorphine Market Snapshot and Growth Engine
4.2 Buprenorphine Market Overview
4.3 Sublingual Tablets
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Sublingual Tablets: Geographic Segmentation Analysis
4.4 Extended-Release Injectables
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Extended-Release Injectables: Geographic Segmentation Analysis
4.5 Buccal Films
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Buccal Films: Geographic Segmentation Analysis
Chapter 5: Buprenorphine Market by Application
5.1 Buprenorphine Market Snapshot and Growth Engine
5.2 Buprenorphine Market Overview
5.3 Pain Management
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Pain Management: Geographic Segmentation Analysis
5.4 Opioid Dependence Treatment
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Opioid Dependence Treatment: Geographic Segmentation Analysis
Chapter 6: Buprenorphine Market by End User
6.1 Buprenorphine Market Snapshot and Growth Engine
6.2 Buprenorphine Market Overview
6.3 Hospitals
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospitals: Geographic Segmentation Analysis
6.4 Clinics
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinics: Geographic Segmentation Analysis
6.5 Homecare Settings)
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Homecare Settings): Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Buprenorphine Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 INDIVIOR (UNITED KINGDOM)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
7.4 MYLAN N.V. (USA)
7.5 JOHNSON & JOHNSON (USA)
7.6 BRISTOL-MYERS SQUIBB (USA)
7.7 PURDUE PHARMA L.P. (USA)
7.8 AMGEN INC. (USA)
7.9 CADILA HEALTHCARE (INDIA) |
7.10 SANDOZ (GERMANY)
7.11 GILEAD SCIENCES (USA)
7.12 OTHER ACTIVE PLAYERS
Chapter 8: Global Buprenorphine Market By Region
8.1 Overview
8.2. North America Buprenorphine Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Product Type
8.2.4.1 Sublingual Tablets
8.2.4.2 Extended-Release Injectables
8.2.4.3 Buccal Films
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Pain Management
8.2.5.2 Opioid Dependence Treatment
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Hospitals
8.2.6.2 Clinics
8.2.6.3 Homecare Settings)
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Buprenorphine Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Product Type
8.3.4.1 Sublingual Tablets
8.3.4.2 Extended-Release Injectables
8.3.4.3 Buccal Films
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Pain Management
8.3.5.2 Opioid Dependence Treatment
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Hospitals
8.3.6.2 Clinics
8.3.6.3 Homecare Settings)
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Buprenorphine Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Product Type
8.4.4.1 Sublingual Tablets
8.4.4.2 Extended-Release Injectables
8.4.4.3 Buccal Films
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Pain Management
8.4.5.2 Opioid Dependence Treatment
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Hospitals
8.4.6.2 Clinics
8.4.6.3 Homecare Settings)
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Buprenorphine Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Product Type
8.5.4.1 Sublingual Tablets
8.5.4.2 Extended-Release Injectables
8.5.4.3 Buccal Films
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Pain Management
8.5.5.2 Opioid Dependence Treatment
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Hospitals
8.5.6.2 Clinics
8.5.6.3 Homecare Settings)
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Buprenorphine Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Product Type
8.6.4.1 Sublingual Tablets
8.6.4.2 Extended-Release Injectables
8.6.4.3 Buccal Films
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Pain Management
8.6.5.2 Opioid Dependence Treatment
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Hospitals
8.6.6.2 Clinics
8.6.6.3 Homecare Settings)
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Buprenorphine Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Product Type
8.7.4.1 Sublingual Tablets
8.7.4.2 Extended-Release Injectables
8.7.4.3 Buccal Films
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Pain Management
8.7.5.2 Opioid Dependence Treatment
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Hospitals
8.7.6.2 Clinics
8.7.6.3 Homecare Settings)
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Q1: What would be the forecast period in the Buprenorphine Market research report?
A1: The forecast period in the Buprenorphine Market research report is 2024-2032.
Q2: Who are the key players in the Buprenorphine Market?
A2: Amgen Inc. (USA),Bristol-Myers Squibb (USA),Cadila Healthcare (India),Gilead Sciences (USA),Indivior (United Kingdom),Johnson & Johnson (USA),Mylan N.V. (USA),Purdue Pharma L.P. (USA),Sandoz (Germany),Teva Pharmaceutical Industries Ltd. (Israel), and Other active Players.
Q3: What are the segments of the Buprenorphine Market?
A3: The Buprenorphine Market is segmented into by Product Type (Sublingual Tablets, Extended-Release Injectables, Buccal Films), Application (Pain Management, Opioid Dependence Treatment), End User (Hospitals, Clinics, Homecare Settings). By region, it is analyzed across North America (U.S., Canada, Mexico),Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe),Western Europe (Germany, UK, France, Netherlands, Italy, Spain, Rest of Western Europe),Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC),Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa),South America (Brazil, Argentina, Rest of SA).
Q4: What is the Buprenorphine Market?
A4: The Buprenorphine Market defines the market of the medicine buprenorphine for the treatment of opioid dependence and pain in the world. Buprenorphine is a partial agonist in the opioid class and is applied to minimize withdrawal and desire in opiate addiction. It is also used for management of pain inclusive of chronic pain disorders. It involves sublingual tablets, extended release injectables, buccal films available in hospitals, pharmacies, and through online sales across the world.
Q5: How big is the Buprenorphine Market?
A5: Buprenorphine Market Size Was Valued at USD 5.44 Billion in 2023, and is Projected to Reach USD 18.25 Billion by 2032, Growing at a CAGR of 14.40% From 2024-2032.
How to Buy a Report from eminsights.jp
On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.
If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.
Click the Buy Now button.
You will be redirected to the checkout page. Enter your company details and payment information.
Click Place Order to complete the purchase.
Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.
If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.
Thank you for choosing eminsights.jp!
